scholarly article | Q13442814 |
P50 | author | Thomas Ten Have | Q57327797 |
Daniel A Weintraub | Q64767919 | ||
Matthew B. Stern | Q67208124 | ||
P2093 | author name string | John E Duda | |
Sarra Nazem | |||
Andrew D Siderowf | |||
Shahrzad Mavandadi | |||
P2860 | cites work | The Spielberger State-Trait Anxiety Inventory (STAI): the state scale in detecting mental disorders in geriatric patients. | Q51927975 |
Development of the University of Pennsylvania Smell Identification Test: a standardized microencapsulated test of olfactory function. | Q52211663 | ||
The inventory for depressive symptomatology (IDS): Preliminary findings | Q61480128 | ||
Depression in Parkinson's disease | Q68694013 | ||
Depression and cognitive impairment in Parkinson's disease | Q69776231 | ||
Depression in patients with early versus late onset of Parkinson's disease | Q69793186 | ||
Parkinson's disease and anxiety: comorbidity with depression | Q72675210 | ||
Pramipexole versus sertraline in the treatment of depression in Parkinson's disease: a national multicenter parallel-group randomized study | Q83139326 | ||
Neuropsychiatric symptoms in patients with Parkinson's disease and dementia: frequency, profile and associated care giver stress | Q24678238 | ||
“Mini-mental state” | Q25938989 | ||
Prevalence, etiology, and treatment of depression in Parkinson's disease | Q28191314 | ||
A New Method for Measuring Daytime Sleepiness: The Epworth Sleepiness Scale | Q28256570 | ||
Parkinsonism: onset, progression, and mortality | Q28259134 | ||
Role of dopamine in learning and memory: implications for the treatment of cognitive dysfunction in patients with Parkinson's disease | Q33985023 | ||
Diagnostic criteria for Parkinson disease | Q34489839 | ||
Range of neuropsychiatric disturbances in patients with Parkinson's disease | Q35453530 | ||
The neuropsychiatry of Parkinson's disease and related disorders | Q35953889 | ||
Frequency and correlates of co-morbid psychosis and depression in Parkinson's disease | Q36011226 | ||
Psychiatric complications in Parkinson disease | Q36285664 | ||
Intervening in the neuropsychiatric features of Parkinson's disease | Q36847266 | ||
Prevalence and correlates of neuropsychiatric symptoms in Parkinson's disease without dementia | Q38387848 | ||
Norms for letter and category fluency: demographic corrections for age, education, and ethnicity | Q38449676 | ||
Neuropsychiatric adverse effects of antiparkinsonian drugs. Characteristics, evaluation and treatment | Q39456220 | ||
The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia | Q39605807 | ||
Parkinson Psychosis Rating Scale: a practical instrument for grading psychosis in Parkinson's disease | Q42538770 | ||
Prevalence and clinical correlates of psychotic symptoms in Parkinson disease: a community-based study | Q48210742 | ||
A profile of neuropsychiatric problems and their relationship to quality of life for Parkinson's disease patients without dementia | Q48462604 | ||
Neuropsychiatric disturbances in Parkinson's disease clusters in five groups with different prevalence of dementia. | Q48540399 | ||
Exacerbated physical fatigue and mental fatigue in Parkinson's disease | Q48681750 | ||
Comorbidity of the nonmotor symptoms of Parkinson's disease | Q48692064 | ||
Insomnia and depressive symptoms in patients with Parkinson's disease. Relationship to health-related quality of life. An interview study of patients living at home | Q48700487 | ||
Reliability, validity, and clinical correlates of apathy in Parkinson's disease | Q48852465 | ||
P433 | issue | 11 | |
P921 | main subject | Parkinson's disease | Q11085 |
P304 | page(s) | 986-995 | |
P577 | publication date | 2009-11-01 | |
P1433 | published in | American Journal of Geriatric Psychiatry | Q15752426 |
P1476 | title | Use of latent variable modeling to delineate psychiatric and cognitive profiles in Parkinson disease | |
P478 | volume | 17 |
Q36849956 | A latent class analysis of psychological disturbance in Parkinson's disease. |
Q34611889 | A proposal for a comprehensive grading of Parkinson's disease severity combining motor and non-motor assessments: meeting an unmet need |
Q37968511 | Cognitive impairment in nondemented Parkinson's disease |
Q36810589 | Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines |
Q91625388 | Education, and the balance between dynamic and stationary functional connectivity jointly support executive functions in relapsing-remitting multiple sclerosis |
Q45733079 | Genetically meaningful phenotypic subgroups in autism spectrum disorders |
Q37442817 | Identifying the Zheng in psoriatic patients based on latent class analysis of traditional Chinese medicine symptoms and signs. |
Q35234522 | MDS Task Force on mild cognitive impairment in Parkinson's disease: critical review of PD-MCI. |
Q40253420 | Neuropsychological Subgroups in Non-Demented Parkinson's Disease: A Latent Class Analysis |
Q33917094 | Parkinson's disease: the quintessential neuropsychiatric disorder |
Q37669734 | Pre-clinical cognitive phenotypes for Alzheimer disease: a latent profile approach |
Q34638941 | Psychosis in Parkinson's disease without dementia: common and comorbid with other non-motor symptoms |
Q64767922 | The Neuropsychiatry of Parkinson Disease: A Perfect Storm |
Q30593620 | The spectrum of cognitive disorders in Parkinson's disease: a data-driven approach |
Search more.